期刊文献+

IL-2基因修饰的肿瘤细胞对小鼠体内巨噬细胞数量和功能的影响 被引量:1

Effects of IL-2 Gene Modified Tumor Cells on the Number and Functions of Peritoneal Macrophages in Vivo
下载PDF
导出
摘要 目的 探讨IL - 2基因修饰的肿瘤细胞对小鼠体内巨噬细胞 (M)数量和功能的影响 .方法 应用腺病毒载体介导的小鼠IL - 2基因 (Ad -mIL - 2 )修饰CT2 6小鼠结肠腺癌细胞 (CT2 6 -mIL - 2 )后皮下接种小鼠 ,计数小鼠腹腔M的数量 ,观察其吞噬功能 ,混合淋巴细胞反应法 (MLR)测定其抗原提呈能力 ,MTT法检测其杀伤活性 .结果 mIL - 2基因修饰的CT2 6细胞 (CT2 6 -mIL - 2细胞 )皮下接种后 ,小鼠腹腔M数量显著增加 ,吞噬能力明显增强 ,抗原提呈能力提高 ,并具有较强的杀伤活性 .结论 CT2 6 -mIL - 2细胞分泌的IL - 2能有效地激活M ,这可能是CT2 6 -mIL - 2细胞体内致瘤性下降的原因之一 . Objective To observe the effects of IL-2 gene modified tumor cells on the number and functions of murine peritoneal macrophages in vivo. Methods CT26 murine colorectal adenocarcinoma cells were transfected with mIL-2 recombinant adenovirus and tumors were established by S.C. implantation of wild CT26 cells or CT26-LacZ cells or CT26-mIL-2 cells. The number of tumor-bearing mice peritoneal macrophage was calculated and the phagocytic activity was observed. The antigen presenting activity of M was detected by mixed lymphocyte reaction (MLR) assay and the cytoxicity of M was measured by MTT assay. Results After inoculation of CT26-mIL-2 cells, the number of peritoneal macrophages increased significantly. The phagocytic activity, the antigen presenting activity and the cytoxicity of M were all augmental strikingly as compared with the control group. Conclusions IL-2 secreted by CT26-mIL-2 cells in vivo has effectively activated the peritoneal macrophages to some extent, which may account for the decrease tumorigenicity of the
出处 《现代临床医学生物工程学杂志》 2003年第5期390-392,共3页 Journal of Modern Clinical Medical Bioengineering
基金 广西教育厅资助项目 (970 93)
关键词 IL-2 基因修饰 肿瘤细胞 小鼠 巨噬细胞 免疫学 IL-2 gene transfected CT26 cells. IL-2 Gene modification Macrophage
  • 相关文献

参考文献6

  • 1曹雪涛,章卫平,顾申,陶群,周正芳,郑玲莉,叶天星.成纤维细胞介导的人白介素6基因疗法增强机体免疫功能的实验研究[J].中国免疫学杂志,1994,10(1):8-12. 被引量:26
  • 2修方明,曹雪涛,马施华,陶群,叶天星.TNF-α基因和IL-2基因共转染的肿瘤细胞体内致瘤性和瘤苗效果的观察[J].中国免疫学杂志,1997,13(2):77-80. 被引量:3
  • 3Parmiani G, Colombo MP, Melani C, et al. Cytokine gene transduction in the immunotherapy of cancer[J]. Adv Pharmacol, 1997,40(2) :259.
  • 4Tanaka hi, Saijo Y, Sato G, et al. Induction of antimour immunity by combined immunogene therapy using IL - 2 and IL - 12 in low antigenic lewis lung carcinoma[J]. Cancer Gene Ther, 2000,7( 11 ) : 1481.
  • 5Lesimple T, Moisan A, Toujas L, et al. Autologous human macrophages and antitumor cell therapy[J] . Res Immunol, 1998,149:663.
  • 6Thomassen M, Antal J, Connors M, et al. Immunomodulatory effects of recombinant IL - 3 treatment on human alveolate macrophages and monocytes [J] . J Immuno Ther, 1993,14:43.

二级参考文献6

共引文献27

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部